What non-stimulant medications treat ADHD?
What non-stimulant medications treat ADHD?
The most commonly used nonstimulant medication, Atomoxetine (Strattera), is a norepinephrine modulator, as is a new medication called Viloxazine (Qelbree). The other two commonly used nonstimulant medications for ADHD,Clonidine (Catapres, Kapvay) and Guanfacine (Tenex, Intuniv) are alpha agonists.
Can ADHD be treated without stimulants?
Non-stimulant ADHD medications come in many varieties: FDA-approved non-stimulants, antidepressants, blood pressure medications, and more. These are second-line treatment options for ADHD patients who don’t respond to stimulant medication, or experience too many side effects.
What is a non-stimulant?
Non-stimulants: Atomoxetine (Strattera) and alpha-2 adrenergics. How they work. Mainly target receptors of the brain chemical dopamine. Very effective at improving attention and reducing hyperactivity and impulsivity.
How does Strattera work for ADHD?
How does Strattera work? This medication works by increasing the amount of norepinephrine, an important chemical in the brain. Doing this appears to help ADHD by increasing attention span and reducing impulsive behavior and hyperactivity.
What does Strattera do for ADHD?
How does Strattera treat ADHD?
Is Strattera or Vyvanse better?
Both medications are effective in improving the symptoms of ADHD. Stimulants like Vyvanse are the most common drug for treating ADHD. However, nonstimulant medications such as Strattera may be a better option for some people, especially those who are not able to tolerate stimulants.
Is Strattera safer than stimulants?
Unlike stimulant drugs, Strattera is not a controlled substance. Therefore, people are less likely to abuse or become dependent on it. In addition, Strattera doesn’t cause many of the potential side effects linked to psychostimulants, such as sleeplessness.
Who needs Strattera?
STRATTERA is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years and older, adolescents and adults. ADHD is a behavioural disorder that causes lack of focus and/or hyperactivity that is much more frequent or severe than others who are close in age or development.
Can Strattera cause weight gain?
Effects on Growth Subsequently, weight gain rebounds and at about 3 years of treatment, patients treated with Strattera have gained 17.9 kg on average, 0.5 kg more than predicted by their baseline data.